Directors

PALO ALTO, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- HP Inc. (NYSE: HPQ) today announced the appointment of David Meline to its Board of Directors. Meline is the former Chief Financial Officer for Moderna Inc., a global biotechnology…

SAN JOSE, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Nubeva Technologies (TSX-V: NBVA) (OTCQB: NBVAF) (“Nubeva” or the “Company”) is pleased to announce the appointment of Francis Chan and Michael KuoFan Lin as independent members of the…

RADNOR, Pa., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other…

TARRYTOWN, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Kathryn Guarini, Ph.D., and David P. Schenkein, M.D., have joined Regeneron’s Board of Directors effective September…

QPR SOFTWARE PLC  STOCK EXCHANGE RELEASE   SEPTEMBER 6, 2023 at 11:30 a.m EEST The Board of Directors of QPR Software Plc Resolved on a New Stock Option Plan Based on the authorization granted by the Annual…

PARIS, FRANCE, 4 September 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Pascal Touchon to its Board as an independent director, effective 4 October 2023, following the decision of Paul Sekhri to step down…

SHENZHEN, China, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei”) (Nasdaq: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced the resignation of Mr. Sean Shenglong Zou and…

CALGARY, Alberta, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Sylogist Ltd. (TSX: SYZ) (“Sylogist” or the “Company”), a leading public sector SaaS company, is pleased to announce that Mr. Errol Olsen has been added as a director of the Company…

CARMEL, Ind., Aug. 24, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions…

NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced the appointment of…